Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,519,501
+$128,638 QoQ
Shares Held
5,983
+5.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#2,589
of 4,664 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Onyx Bridge Wealth Group LLC holds $11,019,132 across 8 Drug Manufacturers - General names. JNJ ranks #4 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
20,486 | $2,632,451 | |
| 2 | LLY |
ELI LILLY & Co
|
1,920 | $2,302,905 | |
| 3 | ABBV |
AbbVie Inc.
|
6,409 | $1,612,760 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
5,983 | $1,519,501 | |
| 5 | PFE |
Pfizer Inc
|
48,247 | $1,161,786 | |
| 6 | AMGN |
Amgen Inc
|
1,929 | $698,529 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,931 | $622,981 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,126 | $468,219 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,519,501 | 5,983 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,390,863 | 5,690 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,150,021 | 5,557 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,062,642 | 5,731 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $695,470 | 4,553 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $764,356 | 4,609 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $681,883 | 4,715 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $834,609 | 5,150 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $748,923 | 5,124 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $838,723 | 5,302 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $928,214 | 5,922 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $812,703 | 5,218 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $834,220 | 5,040 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $409,665 | 2,643 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $384,920 | 2,179 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $343,219 | 2,101 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $393,894 | 2,219 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $388,133 | 2,190 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $584,375 | 3,416 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $461,405 | 2,857 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $427,665 | 2,596 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $379,977 | 2,312 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||